04/23/2026
At industry events this year, our team has been sharing research that is helping shape how minimally invasive valve surgery is viewed in practice.
A recently published 7-year, multi-center study on µAVR using our RAM® device and supporting technology uses a method called propensity matching. This compares patients with similar characteristics to evaluate outcomes more accurately.
Among 259 matched patients, results included 0% 30-day mortality, 0% paravalvular leak, and 0% persistent atrial fibrillation.
Findings like these help build confidence in minimally invasive approaches and support broader adoption, with the goal of improving care and recovery for cardiac patients everywhere.
Explore the research: https://ow.ly/Rn9750YKCLW